SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

GALA is designed to power the Gala Games ecosystem to support gaming re-imagined to benefit creators and players, alike.

Gala Games

Gala Games is experiencing a surge in community engagement as investors debate its potential for a major breakout, with many pointing to upcoming entertainment ecosystem catalysts and the broader gaming token narrative as potential drivers. While some community members remain skeptical of past performance, others are actively accumulating the token, anticipating that the project's utility and long-term roadmap could lead to significant momentum as the wider altcoin market matures.

PENGU is the official coin of Pudgy Penguins.  Pudgy Penguins has become the face of crypto with one of the most influential communities in the industry. From large companies wearing the Penguin, to being featured in ETF commercials, to garnering millions of followers and over 100 billion views, the Pengu has become a cultural icon making PENGU the world’s social currency.  PENGU allows for the ever-expanding Pudgy Penguin fanbase and the hundreds of millions of people outside of crypto that see and share the Pudgy Penguin everyday, to join The Huddle. PENGU is a symbol for community, memes, and good vibes.  Believe in Pengu. Believe in the Prophecy.

Pudgy Penguins

Pudgy Penguins is trending as investors debate the project's transition from a digital NFT collection into a mainstream retail brand with physical merchandise and utility-focused developments. Community members are actively discussing potential catalysts like regulatory updates and upcoming game releases, while remaining divided between those accumulating through market dips and others skeptical of price performance compared to broader crypto volatility.

Invesco DB Agriculture Fund - Common units of beneficial interest

Invesco DB Agriculture Fund

The Invesco DB Agriculture Fund is drawing intense interest from market participants who are betting on a prolonged food supply crisis, with many citing geopolitical tensions in the Middle East and ongoing supply chain disruptions as primary catalysts. Investors are actively debating the fund's role as an inflation hedge and speculating on potential long-term agricultural shortages, with many using the ticker as a cornerstone for bearish outlooks on broader economic stability through 2027.

Avalo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the treatment of immune dysregulation by developing therapies that target the LIGHT-signaling network. It also focuses on reducing LIGHT levels which can moderate immune dysregulation in many acute and chronic inflammatory disorders. The company was founded by Blake M. Paterson, Isaac Blech, Barbara S. Slusher, and Solomon H. Snyder on January 31, 2011 and is headquartered in Wayne, PA.

Avalo Therapeutics Inc

Avalo Therapeutics is currently attracting attention due to high trading volume and anticipation surrounding the Phase 2 LOTUS trial for its lead asset, AVTX-009, with topline data expected mid-2026. While the community is closely tracking technical indicators and potential momentum, there is ongoing debate regarding the company's financial runway and the historical volatility associated with its pipeline development.

Maul Coin

Maul Coin is trending as a high-conviction community project, with members actively debating its potential for long-term growth versus skeptics who label it a pump-and-dump scheme. The community is focused on driving visibility to secure a formal chart, frequently sharing contract addresses and discord links to recruit new holders.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

JasmyCoin is currently facing intense community polarization, with long-term holders debating the project's utility and future prospects while others label it a stagnant or failing asset. Investors remain hyper-focused on technical support levels and broader market trends, with many expressing deep frustration over the lack of consistent momentum compared to newer, more volatile micro-cap alternatives.

VanEck ETF Trust - VanEck Agribusiness ETF

VanEck Agribusiness ETF

VanEck Agribusiness ETF (MOO) is capturing community attention as investors debate its role as a defensive hedge against long-term food insecurity and a potential structural bull market in agricultural commodities. Market participants are actively comparing MOO with futures-based alternatives and specific agribusiness stocks, frequently discussing its potential for a long-term breakout driven by global supply chain volatility and rising commodity prices.

Linea is the Layer 2 built from first principles to strengthen Ethereum and the entire ETH economy. Every aspect of its design—from its productive ETH burn mechanics, and capital efficient native yield, to its underlying Ethereum-equivalent zk tech—amplifies the value and utility of Ethereum Mainnet. All of this is backed by the largest ecosystem fund in the space, managed by the most trusted Ethereum builders. With institutional-grade infrastructure, and deep integration across DeFi, Linea is the best chain for ETH capital, where every transaction and every block strengthens Ethereum. Linea is where Ethereum wins.

Linea

Linea is currently trending due to intense community speculation regarding its potential integration with the SWIFT banking network, with many users contrasting this narrative against XRP. While some investors view the project as an undervalued opportunity backed by Consensys, others are raising concerns about high token unlock schedules and perceived bearish momentum on its price chart.

CME Group, Inc. operates a derivatives marketplace, which offers a range of futures and options products for risk management. Its exchanges offer a range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange (FX), energy, agricultural commodities and metals. It offers futures and options on futures trading across asset classes through the CME Globex platform, fixed income trading via BrokerTec and FX trading on the EBS platform. In addition, it also operates CME Clearing, a central counterparty clearing provider. The company was founded in 1898 and is headquartered in Chicago, IL.

CME Group Inc - Ordinary Shares - Class A

CME Group Inc

CME Group is gaining momentum as market participants increasingly rely on its derivatives and futures platform to navigate heightened volatility, while institutional demand for crypto-linked products and the promise of 24/7 tokenized cash settlement fuel a long-term infrastructure narrative. Community discussions are centered on the exchange's role as a primary beneficiary of the 'degenerate economy'where high-frequency trading, prediction markets, and speculative demand for volatility translate into sustained fee-driven growth.

Autodesk, Inc. engages in the design of software and services. Its products include AutoCAD, BIM Collaborate Pro, Revit, Civil 3D, Fusion 360, InfraWorks, Inventor, Maya, PlanGrid, Revit, Shotgun, and 3ds Max. The firm also offers product development and manufacturing software, which provides manufacturers in the automotive, transportation, industrial machinery, consumer products, and building product industries with digital design, engineering, and production solutions. The firm is also involved in digital media and entertainment, which consists of tools for digital sculpting, modeling, animation, effects, rendering, and compositing for design visualization, visual effects, and games production. The company was founded by John Walker in April 1982 and is headquartered in San Francisco, CA.

Autodesk Inc.

Autodesk is currently drawing significant investor attention as markets digest the company's recent earnings beat, raised full-year guidance, and a strategic restructuring plan that includes a workforce reduction. The community is actively debating the company's long-term growth potential and the impact of these cost-saving measures, while analysts continue to adjust price targets amidst a backdrop of ongoing institutional and activist interest.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$IFRX Mr. C, this link/article might be of interest to you for further information, supplementation, refresher, or other purposes. 
 
I would appreciate a brief, methodically clear explanation for a layperson. Thank you in advance if you accept it. 👍🏻 
 
https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaf681/8571316 
- Update of the clinical practice guideline by the Infectious Diseases Society of America on the treatment of COVID-19: Baricitinib vs. Tocilizumab 
 
April 1, 2026

Marcel G.

Stph

StartSlow

StockTwits Web

InflaRx N.V.

 Mr. C, this link/article might be of interest to you for further information, supplementation, refresher, or other purposes. 
 
I would appreciate a brief, methodically clear explanation for a layperson. Thank you in advance if you accept it. 👍🏻 
 


 
- Update of the clinical practice guideline by the Infectious Diseases Society of America on the treatment of COVID-19: Baricitinib vs. Tocilizumab 
 
April 1, 2026

Alpha Cognition Inc

FlowerInTheCellar

@FlowerInTheCellar That is a mission possible ;) 
 
I usually jump down to the conclusion of these kinds of papers, get the executive summary.  Nothing really changed that I can see.  As it’s been for years now, both JAK signal blocking baricitinib and IL-6 signal blocking tocilizumab are approved to treat severe or critical covid.  As to which is more effective, the IDSA suggests putting them to the test in a comparative-style randomized placebo controlled trial. 
 
I say, while running such a trial, put those mops up against Vilo as well, to also satisfy the IDSA love for more trials to prove established biology and already proven effective and safe biotech that respects said biology, fixing what’s broken.  Common sense healthcare.

 That is a mission possible ;) 
 
I usually jump down to the conclusion of these kinds of papers, get the executive summary.  Nothing really changed that I can see.  As it’s been for years now, both JAK signal blocking baricitinib and IL-6 signal blocking tocilizumab are approved to treat severe or critical covid.  As to which is more effective, the IDSA suggests putting them to the test in a comparative-style randomized placebo controlled trial. 
 
I say, while running such a trial, put those mops up against Vilo as well, to also satisfy the IDSA love for more trials to prove established biology and already proven effective and safe biotech that respects said biology, fixing what’s broken.  Common sense healthcare.